New York State Teachers Retirement System Sells 845 Shares of Axon Enterprise, Inc $AXON

New York State Teachers Retirement System cut its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 1.4% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 58,408 shares of the biotechnology company’s stock after selling 845 shares during the period. New York State Teachers Retirement System owned about 0.07% of Axon Enterprise worth $24,805,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Y Intercept Hong Kong Ltd acquired a new stake in Axon Enterprise in the 1st quarter valued at $1,351,000. Leonteq Securities AG boosted its stake in shares of Axon Enterprise by 79.8% during the 1st quarter. Leonteq Securities AG now owns 5,035 shares of the biotechnology company’s stock worth $2,138,000 after buying an additional 2,234 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its stake in shares of Axon Enterprise by 60.5% during the 1st quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 19,080 shares of the biotechnology company’s stock worth $8,103,000 after buying an additional 7,190 shares during the last quarter. Elevation Point Wealth Partners LLC boosted its stake in shares of Axon Enterprise by 40.9% during the 1st quarter. Elevation Point Wealth Partners LLC now owns 1,523 shares of the biotechnology company’s stock worth $647,000 after buying an additional 442 shares during the last quarter. Finally, Keybank National Association OH grew its holdings in shares of Axon Enterprise by 16.7% in the 1st quarter. Keybank National Association OH now owns 1,007 shares of the biotechnology company’s stock valued at $428,000 after acquiring an additional 144 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In related news, CRO Cameron Brooks sold 1,242 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total value of $621,000.00. Following the sale, the executive owned 49,710 shares in the company, valued at approximately $24,855,000. This represents a 2.44% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 13,000 shares of the stock in a transaction on Friday, June 5th. The shares were sold at an average price of $488.45, for a total value of $6,349,850.00. Following the completion of the sale, the president owned 169,125 shares in the company, valued at approximately $82,609,106.25. This trade represents a 7.14% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 48,989 shares of company stock valued at $24,090,083. Company insiders own 4.20% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on AXON shares. Morgan Stanley set a $600.00 target price on Axon Enterprise in a research report on Thursday, May 7th. Citizens Jmp reissued a “market outperform” rating and set a $700.00 price target on shares of Axon Enterprise in a research report on Thursday, June 25th. Piper Sandler restated an “overweight” rating and issued a $674.00 price target on shares of Axon Enterprise in a research note on Monday, June 15th. Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, May 8th. Finally, Zacks Research upgraded Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 19th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $712.75.

Axon Enterprise Price Performance

Shares of AXON stock opened at $597.04 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. The firm’s 50-day moving average is $437.68 and its 200-day moving average is $482.40. The stock has a market cap of $48.12 billion, a price-to-earnings ratio of 239.78, a PEG ratio of 12.18 and a beta of 1.38. Axon Enterprise, Inc has a 52-week low of $339.01 and a 52-week high of $885.91.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The business had revenue of $807.35 million during the quarter, compared to the consensus estimate of $778.90 million. During the same period last year, the business posted $1.47 EPS. Axon Enterprise’s revenue was up 33.7% on a year-over-year basis. Sell-side analysts predict that Axon Enterprise, Inc will post 1.63 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.